Daiwa Securities Group’s Myriad Genetics MYGN Stock Holding History
Bought
Maintained
Sold
Other funds holding MYGN
GCM
CCM
DGI
Daiwa Securities Group's MYGN Position: Q4 2024 in Review
Daiwa Securities Group sold out of Myriad Genetics (MYGN) in Q4 2024, closing a stake of 326 shares — an estimated $9K sold.
Daiwa Securities Group first reported a position in MYGN in Q1 2014 and held it in 28 quarters. The position peaked at $3.08M in Q1 2014. 221 funds tracked by Wall St. Rank hold MYGN as of Q4 2024.
- Daiwa Securities Group reported no remaining Myriad Genetics position as of Q4 2024 after selling out during the quarter.
- Daiwa Securities Group sold 326 Myriad Genetics shares in Q4 2024, an estimated $9K.
- Daiwa Securities Group first reported a position in Myriad Genetics in Q1 2014 and held it in 28 quarters.
- Daiwa Securities Group's Myriad Genetics position peaked at $3.08M in Q1 2014.
- 221 funds tracked by Wall St. Rank held Myriad Genetics as of Q4 2024.
Based on Daiwa Securities Group's 13F filing for Q4 2024, filed 7 Feb 2025.